Avenue Therapeutics, Inc. (ATXI)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

10

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Apr-24 4:05 PM View:	16-Apr-24 Grant 0	Fortress Biotech, Inc. 10% Owner		Avenue Therapeutics, Inc. - ATXI	244% 1.03M to 3.55M	0	0	--	--	Show Txns Hide Txns

01-Oct-24 4:15 PM View:	30-Sep-24 Purchase $1.24K	Kranzler Jay D Director		Avenue Therapeutics, Inc. - ATXI	417% 0.12K to 0.62K	0	0	--	--	Show Txns Hide Txns

25-Sep-24 4:55 PM View:	23-Sep-24 Grant 0	MacLean Alexandra Chief Executive Officer Director		Avenue Therapeutics, Inc. - ATXI	100% 0 to 170.0K	0	0	--	--	Show Txns Hide Txns

25-Sep-24 4:53 PM View:	23-Sep-24 Grant 0	Jin David Interim PFO and COO		Avenue Therapeutics, Inc. - ATXI	100% 0 to 65.0K	0	0	--	--	Show Txns Hide Txns

13-Dec-23 4:02 PM View:	11-Dec-23 Sale ($49.60K)	Davidow Robert L 10% Owner		Avenue Therapeutics, Inc. - ATXI	(34%) 1.84M to 1.22M	0	0	--	--	Show Txns Hide Txns